'Therapeutic vaccine for AIDS by 2012'

after he was awarded the for discovering HIV 25 years back, French scientist has predicted that there would be a “therapeutic vaccine” for by 2012. Montagnier has shared 2008’s Nobel Prize in medicine with another French researcher Francoise Barre-Sinoussi and Germany’s Harald zur Hausen for discovering the AIDS virus and the role of viruses in cervical cancer.

According to 76-year-old Montagnier, a treatment could be possible in future with a therapeutic vaccine for which the results might be published in three or four years if financial backing is forthcoming.

A therapeutic vaccine normally prevents a disease from flourishing after it has taken hold.

“I think it’ll be possible with a therapeutic vaccine rather than preventative vaccinations. We would give it only to people who are already infected,” the French scientist was quoted by British newspaper ‘The Daily Telegraph’ as saying.

Montagnier and his team, including Barre-Sinoussi, discovered HIV, at the French Pasteur Institute 25 years ago. The work in the early 1980s made it possible to clone the HIV-1 genome.

“The discovery was one prerequisite for the current understanding of biology of the disease and its antiretroviral treatment,” according to a statement issued by Nobel Assembly of Sweden’s Karolinska Institute.

image
Business Standard
177 22
Business Standard

'Therapeutic vaccine for AIDS by 2012'

Press Trust Of India  |  London 



after he was awarded the for discovering HIV 25 years back, French scientist has predicted that there would be a “therapeutic vaccine” for by 2012. Montagnier has shared 2008’s Nobel Prize in medicine with another French researcher Francoise Barre-Sinoussi and Germany’s Harald zur Hausen for discovering the AIDS virus and the role of viruses in cervical cancer.

According to 76-year-old Montagnier, a treatment could be possible in future with a therapeutic vaccine for which the results might be published in three or four years if financial backing is forthcoming.

A therapeutic vaccine normally prevents a disease from flourishing after it has taken hold.

“I think it’ll be possible with a therapeutic vaccine rather than preventative vaccinations. We would give it only to people who are already infected,” the French scientist was quoted by British newspaper ‘The Daily Telegraph’ as saying.

Montagnier and his team, including Barre-Sinoussi, discovered HIV, at the French Pasteur Institute 25 years ago. The work in the early 1980s made it possible to clone the HIV-1 genome.

“The discovery was one prerequisite for the current understanding of biology of the disease and its antiretroviral treatment,” according to a statement issued by Nobel Assembly of Sweden’s Karolinska Institute.

RECOMMENDED FOR YOU

'Therapeutic vaccine for AIDS by 2012'

Barely a day after he was awarded the Nobel Prize in medicine for discovering HIV 25 years back, French scientist Luc Montagnier has predicted that there would be a “therapeutic vaccine”

after he was awarded the for discovering HIV 25 years back, French scientist has predicted that there would be a “therapeutic vaccine” for by 2012. Montagnier has shared 2008’s Nobel Prize in medicine with another French researcher Francoise Barre-Sinoussi and Germany’s Harald zur Hausen for discovering the AIDS virus and the role of viruses in cervical cancer.

According to 76-year-old Montagnier, a treatment could be possible in future with a therapeutic vaccine for which the results might be published in three or four years if financial backing is forthcoming.

A therapeutic vaccine normally prevents a disease from flourishing after it has taken hold.

“I think it’ll be possible with a therapeutic vaccine rather than preventative vaccinations. We would give it only to people who are already infected,” the French scientist was quoted by British newspaper ‘The Daily Telegraph’ as saying.

Montagnier and his team, including Barre-Sinoussi, discovered HIV, at the French Pasteur Institute 25 years ago. The work in the early 1980s made it possible to clone the HIV-1 genome.

“The discovery was one prerequisite for the current understanding of biology of the disease and its antiretroviral treatment,” according to a statement issued by Nobel Assembly of Sweden’s Karolinska Institute.

image
Business Standard
177 22

More News

  • Govt girds for next RCEP trade talks Govt girds up for next round of RCEP talks
  • Revised DTAA between India and Cyprus gets nod
Widgets Magazine

Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard